How long can I take Ketorolac tablets?

Systemic use of ketorolac is only Suggested for the short-term Management of moderately severe acute pain that needs analgesia at The opioid degree. The oral pills are just indicated as continuation treatment after IV or IM administration, if needed.

Restrict Length of usage so the total combined period of use of dental and parenteral ketorolac doesn’t exceed 5 times due to the increased Threat of acute adverse events.

Additionally, doses greater than recommended will Not increase efficiency but will increase the chance of developing serious negative events! the highest recommended daily oral dose is considerably lower than the maximum daily parenteral dose.

Maximum Dosage for Humans

Adults

  • >= 50 kg: 120 mg/day IV/IM, 40 mg/day PO, or 126 mg/day intranasally for no more than 5 days; ophthalmic dosage is indication and product specific.
  • < 50 kg and/or with CrCl < 30 ml/min: 60 mg/day IV/IM, 40 mg/day PO, or 63 mg/day intranasally for no more than 5 days; ophthalmic dosage is indication and product specific.

Geriatric

60 mg/day IV/IM, 40 mg/day PO, or 63 mg/day intranasally for no more than 5 days; ophthalmic dosage is indication and product specific.

Adolescents

  • 17 years and >= 50 kg: 120 mg/day IV/IM or 40 mg/day PO for no more than 5 days; safety and efficacy have not been established for intranasal use; ophthalmic dosage is indication and product specific.
  • 17 years and < 50 kg and/or with CrCl < 30 mL/min: 60 mg/day IV/IM or 40 mg/day PO for no more than 5 days; safety and efficacy have not been established for intranasal use; ophthalmic dosage is indication and product specific.
  • 13—16 years: 0.5 mg/kg IV (Max: 15 mg IV) or 1 mg/kg IM (Max: 30 mg IM) times one dose; safety and efficacy have not been established for oral or intranasal use; ophthalmic dosage is indication and product specific.

Children

  • >= 3 years: 0.5 mg/kg IV (Max: 15 mg IV) or 1 mg/kg IM (Max: 30 mg IM) times one dose; safety and efficacy have not been established for oral or intranasal use; ophthalmic maximum dosage is indication and product specific.
  • 2 years: 0.5 mg/kg IV (Max: 15 mg IV) or 1 mg/kg IM (Max: 30 mg IM) times one dose; ophthalmic maximum dosage is indication and product specific; safety and efficacy have not been established for oral or intranasal use.
  • < 2 years: Safety and efficacy have not been established.